Regulators in India approved a glucose monitoring system made by Abbott (NYSE:ABT) that’s designed to track patients’ blood sugar levels for up to 2 weeks.
Former Evalve CEO Ferolyn Powell, who led the MitraClip developer to a $410 million acquisition by Abbott (NYSE:ABT), died this month in a motorbike accident in northern Thailand, her family said yesterday.
A large clinical trial comparing computed-tomography angiography with functional testing found no benefit to clinical outcomes with CTA, which also exposes patients to large doses of radiation.